معرفی
Professor Graham Davies is a Professor of Clinical Pharmacy & Therapeutics and Senior Academic Lead at the School of Applied Sciences, University of Brighton. His research focuses on medication-related harm in elderly populations, pharmacokinetics in critical care, burns patients, and thromboembolic disease. He leads the PRIME research group, collaborating across academic and clinical institutions to develop risk stratification tools for medication safety. His work spans hospital pharmacy practice, clinical decision-making, and interdisciplinary healthcare improvement.
Education: PhD in Drug Removal in Continuous Renal Replacement Therapy (University of Brighton, 1996). Academic qualifications include BPharm, MSc, and advanced clinical pharmacy training.
Research interests emphasize frailty, polypharmacy, and adverse drug reactions in older adults. Key projects include evaluating healthcare utilization due to medication harm and validating clinical judgment frameworks for pharmacists.
Collaborations involve Brighton & Sussex Medical School, King's College London, and NHS Trusts. His publications address pharmacists' roles in risk prediction, Beers Criteria efficacy, and hypertension medication safety.
